Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back



Editorial (Thematic Issue: Recent Advances in Proteasome Inhibitor-Based Cancer Therapies) free to download

Volume:14   Issue:6
Pp: 505-505
Q. Ping Dou
DOI: 10.2174/1568009614666140805163018

The Immunoproteasome as a Therapeutic Target for Hematological Malignancies

Volume:14   Issue:6
Pp: 537-548
Zachary Miller, Wooin Lee and Kyung Bo Kim
DOI: 10.2174/1568009614666140723113139

NEDD4: A Promising Target for Cancer Therapy

Volume:14   Issue:6
Pp: 549-556
Xiantao Ye, Lixia Wang, Bingxue Shang, Zhiwei Wang and Wenyi Wei
DOI: 10.2174/1568009614666140725092430

Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis

Volume:14   Issue:6
Pp: 557-566
Meng-Hang Yang, Yuan-Sheng Zang, Hai Huang, Kun Chen, Bing Li, Guang-Yuan Sun and Xue-Wei Zhao
DOI: 10.2174/1568009614666140725090000

Structure, Function, and Pathogenesis of SHP2 in Developmental Disorders and Tumorigenesis

Volume:14   Issue:6
Pp: 567-588
Wen-Qing Huang, Qing Lin, Xuan Zhuang, Liang-Liang Cai, Run-Sheng Ruan, Zhong-Xian Lu and Chi-Meng Tzeng
DOI: 10.2174/1568009614666140717105001

Efficacy and Safety of Combined Radiotherapy with EGFR Inhibitors and Chemotherapy for Laryngeal Organ Preservation in Patients with Locally Advanced Hypopharyngeal Carcinomas

Volume:14   Issue:6
Pp: 589-598
Xinxin Zhang, Jailing Wang, Wenming Wu, Mingbo Liu, Feifang Zhao, Lei Du, Deliang Huang, Shiming Yang and Lin Ma
DOI: 10.2174/1568009614666140716115349